Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,172.60
+9.00 (0.77%)
At close: Dec 10, 2025
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.